# Nexium Dyspepsia/AST

> **NCT00251992** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1200 (—)

## Conditions studied

- Gastrointestinal Disease
- Signs and Symptoms, Digestive
- Dyspepsia

## Interventions

- **DRUG:** Esomeprazole

## Key facts

- **NCT ID:** NCT00251992
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** 2005-01
- **Final completion:** 2005-01
- **Target enrollment:** 1200 (—)
- **Last updated:** 2011-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00251992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00251992, "Nexium Dyspepsia/AST". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00251992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*